Clinical Monoclonal B Lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: A Comparison of Cellular, Cytogenetic, Molecular, and Clinical FeaturesFortunato Morabito, Antonino Neri, Laura Mosca et al.|Clinical Cancer Research|2013Cited by 68
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patientsMassimo Gentile, Fortunato Morabito, Tait D. Shanafelt et al.|Leukemia|2015Cited by 35
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL studyMassimo Gentile, Valter Gattei, Fortunato Morabito et al.|Leukemia|2020Cited by 24
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatmentFortunato Morabito, Antonino Neri, Giovanna Cutrona et al.|Leukemia Research|2015Cited by 23
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trialsMassimo Gentile, Pellegrino Musto, Ernesto Vigna et al.|Haematologica|2023Cited by 19